United Therapeutics | Pasivo Circulante



Current Liabilities Cambio Fecha
Amarin USD 162.41M 17.54M 2025-03
Ardelyx USD 81.72M 3.89M 2025-06
Baxter International USD 3.48B 3.03B 2025-03
Bayer EUR 29.78B 1.82B 2025-06
Biogen USD 3.18B 2.11B 2025-06
BioMarin Pharmaceutical USD 684.25M 56.03M 2025-06
Gilead Sciences USD 11.19B 1.15B 2025-06
GlaxoSmithKline GBP 20.38B 453M 2025-06
Halozyme Therapeutics USD 134.28M 16.1M 2025-06
Insmed USD 311.68M 72.45M 2025-06
Ionis Pharmaceuticals USD 897.24M 646.94M 2025-06
J&J USD 56.9B 6.58B 2025-03
Moderna USD 1.57B 32M 2025-06
Pfizer USD 37.73B 1.27B 2025-06
PTC Therapeutics USD 627.81M 32.42M 2025-06
Regeneron Pharmaceuticals USD 3.67B 100.4M 2025-06
Sarepta Therapeutics USD 919.95M 314.36M 2025-06
Teva Pharmaceutical Industries USD 11.86B 704M 2025-06
United Therapeutics USD 527.1M 194.4M 2025-06
Vertex Pharmaceuticals USD 4.14B 355.2M 2025-06


United Therapeutics Pasivo Circulante - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Sep 2025.